Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy
The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patien...
Saved in:
Published in | Clinica chimica acta Vol. 455; pp. 113 - 117 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.04.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-8981 1873-3492 1873-3492 |
DOI | 10.1016/j.cca.2016.02.003 |
Cover
Abstract | The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects.
This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured.
Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR.
Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects.
•Fetuin-A was positively correlated with VEGF and CRP in T2DM patients.•VEGF was positively correlated with CRP in T2DM patients.•Fetuin-A was independently related with VEGF and CRP in DR patients, but not in NDR.•DR patients had higher HOMA-IR compared with NDR and control subjects. |
---|---|
AbstractList | The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects.BACKGROUNDThe higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects.This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured.METHODSThis study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured.Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR.RESULTSSignificant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR.Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects.CONCLUSIONSSerum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects. The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured. Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR. Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects. The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured. Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR. Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects. •Fetuin-A was positively correlated with VEGF and CRP in T2DM patients.•VEGF was positively correlated with CRP in T2DM patients.•Fetuin-A was independently related with VEGF and CRP in DR patients, but not in NDR.•DR patients had higher HOMA-IR compared with NDR and control subjects. |
Author | Ji, Fei Sun, Ming-Zhong Chen, Hong-Mei Zhou, Zhong-Wei Ju, Hui-Xiang Jiang, Dong-Mei Fu, Qing-Ping Ji, Hong-Bin |
Author_xml | – sequence: 1 givenname: Zhong-Wei surname: Zhou fullname: Zhou, Zhong-Wei organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 2 givenname: Hui-Xiang surname: Ju fullname: Ju, Hui-Xiang email: jhxycsy@163.com organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 3 givenname: Ming-Zhong surname: Sun fullname: Sun, Ming-Zhong organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 4 givenname: Qing-Ping surname: Fu fullname: Fu, Qing-Ping organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 5 givenname: Hong-Mei surname: Chen fullname: Chen, Hong-Mei organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 6 givenname: Hong-Bin surname: Ji fullname: Ji, Hong-Bin organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 7 givenname: Fei surname: Ji fullname: Ji, Fei organization: Department of Ophthalmology, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China – sequence: 8 givenname: Dong-Mei surname: Jiang fullname: Jiang, Dong-Mei organization: Department of Endocrinology, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26851648$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UctuFDEQtFAQ2QQ-gAvykcsM9tjzEqdoxUuKxAE4Wx67h_XKaw-2Z6P9Mb6PDptw4JBL2-2uqraqrshFiAEIec1ZzRnv3u1rY3Td4LVmTc2YeEY2fOhFJeTYXJANY2yshnHgl-Qq5z22knX8BblsuqHlnRw25Pc3SOuBzlBWF6ob6uEIPlOdgLpgYQEsofgTNTEl8LqApXeu7OhRZ7N6nSgiYtmBd9rTnyne4WzWpsREdbB0WyXAzh2BLikWcAGVgkHNpIuLIeMaWk4L0IZapycoztAFR4jI503_nhPWEHG4O70kz2ftM7x6OK_Jj48fvm8_V7dfP33Z3txWRrSiVF1rezG2gkne98yMBibZWpDQTYMd7SRlP0o763megbXNJGY7DrNoWd-YptdSXJO3Z138_K8VclEHlw14rwPENSuUlbztR94i9M0DdJ0OYNWS3EGnk3r0GgH9GWBSzDnBrIwrf01AL5xXnKn7VNVeYarqPlXFGoWpIpP_x3wUf4rz_szBOOHoIKls0FQD1iUwRdnonmD_AZSSvsA |
CitedBy_id | crossref_primary_10_1007_s40200_024_01533_0 crossref_primary_10_1016_j_dsx_2019_07_026 crossref_primary_10_1016_j_tibtech_2016_12_006 crossref_primary_10_1016_j_cyto_2017_10_028 crossref_primary_10_1007_s13410_024_01422_5 crossref_primary_10_1016_j_aca_2022_340169 crossref_primary_10_1007_s12020_017_1383_5 crossref_primary_10_1016_j_ajo_2017_12_022 crossref_primary_10_1155_2019_9401628 crossref_primary_10_1177_09287329241295877 crossref_primary_10_3390_proteomes8030025 crossref_primary_10_1007_s40618_017_0697_8 crossref_primary_10_3389_fimmu_2018_01302 crossref_primary_10_4236_ojoph_2017_72011 crossref_primary_10_1080_02713683_2023_2276683 crossref_primary_10_1186_s43162_022_00152_6 crossref_primary_10_1097_MEG_0000000000001354 crossref_primary_10_4103_1673_5374_350192 |
Cites_doi | 10.1007/s00125-014-3177-0 10.1016/j.phrs.2015.05.013 10.1111/j.1464-5491.2007.02217.x 10.1111/j.1582-4934.2005.tb00379.x 10.2337/dc10-0788 10.1016/j.metabol.2014.03.008 10.1016/j.preteyeres.2011.05.002 10.1007/BF00280883 10.1016/j.ajo.2009.07.007 10.1080/09286580601139220 10.3109/1354750X.2012.762806 10.1038/hr.2009.8 10.1016/j.exer.2006.01.016 10.1002/path.4403 10.12659/MSM.893403 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.1167/iovs.11-9119 10.2337/dc12-1591 10.2337/diacare.29.04.06.dc05-1938 10.1016/j.cca.2015.03.030 10.1189/jlb.1205718 10.3892/mmr.2015.3800 10.1155/2014/790902 10.1007/s10238-009-0084-7 10.1111/dme.12274 10.1371/journal.pone.0001765 10.1038/nm.2851 10.1507/endocrj.EJ15-0152 10.2174/1566524014666140128114414 |
ContentType | Journal Article |
Copyright | 2016 Elsevier B.V. Copyright © 2016 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2016 Elsevier B.V. – notice: Copyright © 2016 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.cca.2016.02.003 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1873-3492 |
EndPage | 117 |
ExternalDocumentID | 26851648 10_1016_j_cca_2016_02_003 S0009898116300468 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29B 4.4 457 4G. 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AAOAW AAQFI AAXUO ABBQC ABFRF ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W K-O KOM L7B LCYCR LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SDF SDG SDP SES SPCBC SSH SSU SSZ T5K WH7 ZA5 ~02 ~G- .55 .GJ 53G AALRI AAQXK AATTM AAXKI AAYWO AAYXX ABDPE ABFNM ABWVN ABXDB ACIEU ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HLW HVGLF HZ~ J5H R2- SBG SEW WUQ X7M XPP ZGI CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c353t-65d73953041770c9ceb45de4e6b8d9db44794dfafffe052b3fd98f35072c27a43 |
IEDL.DBID | AIKHN |
ISSN | 0009-8981 1873-3492 |
IngestDate | Fri Sep 05 06:24:58 EDT 2025 Thu Apr 03 07:02:34 EDT 2025 Tue Jul 01 03:31:50 EDT 2025 Thu Apr 24 23:00:00 EDT 2025 Fri Feb 23 02:24:04 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Diabetic retinopathy Fetuin-A C-reactive protein Type 2 diabetes mellitus Vascular endothelial growth factor |
Language | English |
License | Copyright © 2016 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c353t-65d73953041770c9ceb45de4e6b8d9db44794dfafffe052b3fd98f35072c27a43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26851648 |
PQID | 1774157915 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1774157915 pubmed_primary_26851648 crossref_citationtrail_10_1016_j_cca_2016_02_003 crossref_primary_10_1016_j_cca_2016_02_003 elsevier_sciencedirect_doi_10_1016_j_cca_2016_02_003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-04-01 2016-04-00 2016-Apr-01 20160401 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Clinica chimica acta |
PublicationTitleAlternate | Clin Chim Acta |
PublicationYear | 2016 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Tang, Kern (bb0025) 2011; 30 Stefan, Hennige, Staiger, Machann, Schick, Krober (bb0150) 2006; 29 Zhang, Wang, Schachat, Bao, Gillies (bb0035) 2014; 14 Zhao, Lin, Wu, Luo, Fan, Dong (bb0105) 2013; 18 Lorant, Grujicic, Hoebaus, Brix, Hoellerl, Schernthaner (bb0110) 2011; 34 Nowak, Wielkoszynski, Marek, Kos-Kudla, Swietochowska, Sieminska (bb0030) 2010; 10 Pal, Dasgupta, Kundu, Maitra, Das, Mukhopadhyay (bb0135) 2012; 18 Zittermann, Issekutz (bb0090) 2006; 80 Hennige, Staiger, Wicke, Machicao, Fritsche, Haring (bb0050) 2008; 3 Rajamani, Jialal (bb0130) 2014; 2014 Liu, Hamnvik, Chamberland, Petrou, Gong, Christophi (bb0160) 2014; 63 Byrne, Bouchier-Hayes, Harmey (bb0020) 2005; 9 Zhao, Hou, Wang, Jiang (bb0120) 2015; 21 Anan, Takayuki, Takahashi, Nakagawa, Eshima, Saikawa (bb0140) 2009; 32 Nakao, Arima, Ishikawa, Kohno, Kawahara, Miyazaki (bb0040) 2012; 53 Jensen, Bartz, Mukamal, Djousse, Kizer, Tracy (bb0125) 2013; 36 Noort, van Zoest, Weijers, Koolwijk, Maracle, Novack (bb0100) 2014; 234 Xiao, Jia, Zhang, Wei, Wang, Wu (bb0095) 2015; 12 Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0075) 1985; 28 Tung, Shih, Tsai, Chou, Chen, Lee (bb0145) 2007; 14 Spijkerman, Gall, Tarnow, Twisk, Lauritzen, Lund-Andersen (bb0010) 2007; 24 Yin, Cai, Zhu, Li, Su, Wang (bb0155) 2015; 8 Siegel-Axel, Ullrich, Stefan, Rittig, Gerst, Klingler (bb0055) 2014; 57 Echouffo-Tcheugui, Ali, Roglic, Hayward, Narayan (bb0005) 2013; 30 Behl, Kotwani (bb0015) 2015; 99 Ou, Lu, Wu, Hung, Wu, Yang (bb0115) 2015; 445 Srinivas, Wagner, Reddy, Deutsch, Leon, Goustin (bb0045) 1993; 7 Arjamaa, Nikinmaa (bb0080) 2006; 83 Zhou, Ju, Sun, Chen, Ji, Jiang (bb0060) 2015; 62 Wang, Wang, Wang (bb0085) 2009; 148 Alberti, Zimmet (bb0065) 1998; 15 Jian-gao (bb0070) 2010; 18 Siegel-Axel (10.1016/j.cca.2016.02.003_bb0055) 2014; 57 Stefan (10.1016/j.cca.2016.02.003_bb0150) 2006; 29 Srinivas (10.1016/j.cca.2016.02.003_bb0045) 1993; 7 Jensen (10.1016/j.cca.2016.02.003_bb0125) 2013; 36 Zhao (10.1016/j.cca.2016.02.003_bb0105) 2013; 18 Behl (10.1016/j.cca.2016.02.003_bb0015) 2015; 99 Tung (10.1016/j.cca.2016.02.003_bb0145) 2007; 14 Zhao (10.1016/j.cca.2016.02.003_bb0120) 2015; 21 Nowak (10.1016/j.cca.2016.02.003_bb0030) 2010; 10 Byrne (10.1016/j.cca.2016.02.003_bb0020) 2005; 9 Pal (10.1016/j.cca.2016.02.003_bb0135) 2012; 18 Zhou (10.1016/j.cca.2016.02.003_bb0060) 2015; 62 Jian-gao (10.1016/j.cca.2016.02.003_bb0070) 2010; 18 Xiao (10.1016/j.cca.2016.02.003_bb0095) 2015; 12 Wang (10.1016/j.cca.2016.02.003_bb0085) 2009; 148 Noort (10.1016/j.cca.2016.02.003_bb0100) 2014; 234 Zittermann (10.1016/j.cca.2016.02.003_bb0090) 2006; 80 Echouffo-Tcheugui (10.1016/j.cca.2016.02.003_bb0005) 2013; 30 Liu (10.1016/j.cca.2016.02.003_bb0160) 2014; 63 Rajamani (10.1016/j.cca.2016.02.003_bb0130) 2014; 2014 Yin (10.1016/j.cca.2016.02.003_bb0155) 2015; 8 Ou (10.1016/j.cca.2016.02.003_bb0115) 2015; 445 Hennige (10.1016/j.cca.2016.02.003_bb0050) 2008; 3 Matthews (10.1016/j.cca.2016.02.003_bb0075) 1985; 28 Lorant (10.1016/j.cca.2016.02.003_bb0110) 2011; 34 Alberti (10.1016/j.cca.2016.02.003_bb0065) 1998; 15 Nakao (10.1016/j.cca.2016.02.003_bb0040) 2012; 53 Arjamaa (10.1016/j.cca.2016.02.003_bb0080) 2006; 83 Zhang (10.1016/j.cca.2016.02.003_bb0035) 2014; 14 Spijkerman (10.1016/j.cca.2016.02.003_bb0010) 2007; 24 Tang (10.1016/j.cca.2016.02.003_bb0025) 2011; 30 Anan (10.1016/j.cca.2016.02.003_bb0140) 2009; 32 |
References_xml | – volume: 30 start-page: 343 year: 2011 end-page: 358 ident: bb0025 article-title: Inflammation in diabetic retinopathy publication-title: Prog. Retin. Eye Res. – volume: 8 start-page: 991 year: 2015 end-page: 999 ident: bb0155 article-title: Association of plasma fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus publication-title: Int. J. Clin. Exp. Med. – volume: 445 start-page: 133 year: 2015 end-page: 138 ident: bb0115 article-title: Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness publication-title: Clin. Chim. Acta – volume: 148 start-page: 883 year: 2009 end-page: 889 ident: bb0085 article-title: Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy publication-title: Am J. Ophthalmol. – volume: 36 start-page: 1222 year: 2013 end-page: 1228 ident: bb0125 article-title: Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study publication-title: Diabetes Care – volume: 14 start-page: 376 year: 2014 end-page: 384 ident: bb0035 article-title: Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema publication-title: Curr. Mol. Med. – volume: 83 start-page: 473 year: 2006 end-page: 483 ident: bb0080 article-title: Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors publication-title: Exp. Eye Res. – volume: 32 start-page: 299 year: 2009 end-page: 305 ident: bb0140 article-title: Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients publication-title: Hypertens. Res. – volume: 12 start-page: 3315 year: 2015 end-page: 3322 ident: bb0095 article-title: Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis publication-title: Mol. Med. Rep. – volume: 80 start-page: 247 year: 2006 end-page: 257 ident: bb0090 article-title: Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation publication-title: J. Leukoc. Biol. – volume: 30 start-page: 1272 year: 2013 end-page: 1292 ident: bb0005 article-title: Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review publication-title: Diabet. Med. – volume: 14 start-page: 148 year: 2007 end-page: 154 ident: bb0145 article-title: A community-based study of the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type II diabetics in Kinmen, Taiwan publication-title: Ophthalmic Epidemiol. – volume: 3 year: 2008 ident: bb0050 article-title: Fetuin-A induces cytokine expression and suppresses adiponectin production publication-title: PLoS One – volume: 18 start-page: 163 year: 2010 end-page: 166 ident: bb0070 article-title: Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition publication-title: Zhonghua Gan Zang Bing Za Zhi – volume: 34 start-page: 156 year: 2011 end-page: 161 ident: bb0110 article-title: Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease publication-title: Diabetes Care – volume: 63 start-page: 773 year: 2014 end-page: 782 ident: bb0160 article-title: Circulating alanine transaminase (ALT) and gamma-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus metabolism study publication-title: Metabolism – volume: 9 start-page: 777 year: 2005 end-page: 794 ident: bb0020 article-title: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF) publication-title: J. Cell. Mol. Med. – volume: 53 start-page: 4323 year: 2012 end-page: 4328 ident: bb0040 article-title: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 29 start-page: 853 year: 2006 end-page: 857 ident: bb0150 article-title: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans publication-title: Diabetes Care – volume: 7 start-page: 1445 year: 1993 end-page: 1455 ident: bb0045 article-title: Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level publication-title: Mol. Endocrinol. – volume: 234 start-page: 375 year: 2014 end-page: 385 ident: bb0100 article-title: NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis publication-title: J. Pathol. – volume: 2014 start-page: 790902 year: 2014 ident: bb0130 article-title: Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy publication-title: J. Diabetes Res. – volume: 15 start-page: 539 year: 1998 end-page: 553 ident: bb0065 article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation publication-title: Diabet. Med. – volume: 99 start-page: 137 year: 2015 end-page: 148 ident: bb0015 article-title: Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy publication-title: Pharmacol. Res. – volume: 28 start-page: 412 year: 1985 end-page: 419 ident: bb0075 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – volume: 62 start-page: 879 year: 2015 end-page: 885 ident: bb0060 article-title: Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes publication-title: Endocr. J. – volume: 24 start-page: 969 year: 2007 end-page: 976 ident: bb0010 article-title: Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes publication-title: Diabet. Med. – volume: 18 start-page: 160 year: 2013 end-page: 164 ident: bb0105 article-title: Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes publication-title: Biomarkers – volume: 21 start-page: 1839 year: 2015 end-page: 1842 ident: bb0120 article-title: Relation of serum and vitreous concentrations of fetuin-A with diabetic retinopathy publication-title: Med. Sci. Monit. – volume: 57 start-page: 1057 year: 2014 end-page: 1066 ident: bb0055 article-title: Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells publication-title: Diabetologia – volume: 18 start-page: 1279 year: 2012 end-page: 1285 ident: bb0135 article-title: Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance publication-title: Nat. Med. – volume: 10 start-page: 185 year: 2010 end-page: 192 ident: bb0030 article-title: Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy publication-title: Clin. Exp. Med. – volume: 57 start-page: 1057 year: 2014 ident: 10.1016/j.cca.2016.02.003_bb0055 article-title: Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells publication-title: Diabetologia doi: 10.1007/s00125-014-3177-0 – volume: 99 start-page: 137 year: 2015 ident: 10.1016/j.cca.2016.02.003_bb0015 article-title: Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2015.05.013 – volume: 24 start-page: 969 year: 2007 ident: 10.1016/j.cca.2016.02.003_bb0010 article-title: Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes publication-title: Diabet. Med. doi: 10.1111/j.1464-5491.2007.02217.x – volume: 8 start-page: 991 year: 2015 ident: 10.1016/j.cca.2016.02.003_bb0155 article-title: Association of plasma fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus publication-title: Int. J. Clin. Exp. Med. – volume: 9 start-page: 777 year: 2005 ident: 10.1016/j.cca.2016.02.003_bb0020 article-title: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF) publication-title: J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2005.tb00379.x – volume: 18 start-page: 163 year: 2010 ident: 10.1016/j.cca.2016.02.003_bb0070 article-title: Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition publication-title: Zhonghua Gan Zang Bing Za Zhi – volume: 34 start-page: 156 year: 2011 ident: 10.1016/j.cca.2016.02.003_bb0110 article-title: Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease publication-title: Diabetes Care doi: 10.2337/dc10-0788 – volume: 63 start-page: 773 year: 2014 ident: 10.1016/j.cca.2016.02.003_bb0160 article-title: Circulating alanine transaminase (ALT) and gamma-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus metabolism study publication-title: Metabolism doi: 10.1016/j.metabol.2014.03.008 – volume: 30 start-page: 343 year: 2011 ident: 10.1016/j.cca.2016.02.003_bb0025 article-title: Inflammation in diabetic retinopathy publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2011.05.002 – volume: 28 start-page: 412 year: 1985 ident: 10.1016/j.cca.2016.02.003_bb0075 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 148 start-page: 883 year: 2009 ident: 10.1016/j.cca.2016.02.003_bb0085 article-title: Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy publication-title: Am J. Ophthalmol. doi: 10.1016/j.ajo.2009.07.007 – volume: 14 start-page: 148 year: 2007 ident: 10.1016/j.cca.2016.02.003_bb0145 article-title: A community-based study of the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type II diabetics in Kinmen, Taiwan publication-title: Ophthalmic Epidemiol. doi: 10.1080/09286580601139220 – volume: 18 start-page: 160 year: 2013 ident: 10.1016/j.cca.2016.02.003_bb0105 article-title: Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes publication-title: Biomarkers doi: 10.3109/1354750X.2012.762806 – volume: 32 start-page: 299 year: 2009 ident: 10.1016/j.cca.2016.02.003_bb0140 article-title: Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients publication-title: Hypertens. Res. doi: 10.1038/hr.2009.8 – volume: 83 start-page: 473 year: 2006 ident: 10.1016/j.cca.2016.02.003_bb0080 article-title: Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors publication-title: Exp. Eye Res. doi: 10.1016/j.exer.2006.01.016 – volume: 234 start-page: 375 year: 2014 ident: 10.1016/j.cca.2016.02.003_bb0100 article-title: NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis publication-title: J. Pathol. doi: 10.1002/path.4403 – volume: 21 start-page: 1839 year: 2015 ident: 10.1016/j.cca.2016.02.003_bb0120 article-title: Relation of serum and vitreous concentrations of fetuin-A with diabetic retinopathy publication-title: Med. Sci. Monit. doi: 10.12659/MSM.893403 – volume: 15 start-page: 539 year: 1998 ident: 10.1016/j.cca.2016.02.003_bb0065 article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation publication-title: Diabet. Med. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S – volume: 53 start-page: 4323 year: 2012 ident: 10.1016/j.cca.2016.02.003_bb0040 article-title: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.11-9119 – volume: 36 start-page: 1222 year: 2013 ident: 10.1016/j.cca.2016.02.003_bb0125 article-title: Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study publication-title: Diabetes Care doi: 10.2337/dc12-1591 – volume: 29 start-page: 853 year: 2006 ident: 10.1016/j.cca.2016.02.003_bb0150 article-title: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans publication-title: Diabetes Care doi: 10.2337/diacare.29.04.06.dc05-1938 – volume: 445 start-page: 133 year: 2015 ident: 10.1016/j.cca.2016.02.003_bb0115 article-title: Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2015.03.030 – volume: 80 start-page: 247 year: 2006 ident: 10.1016/j.cca.2016.02.003_bb0090 article-title: Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.1205718 – volume: 7 start-page: 1445 year: 1993 ident: 10.1016/j.cca.2016.02.003_bb0045 article-title: Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level publication-title: Mol. Endocrinol. – volume: 12 start-page: 3315 year: 2015 ident: 10.1016/j.cca.2016.02.003_bb0095 article-title: Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.3800 – volume: 2014 start-page: 790902 year: 2014 ident: 10.1016/j.cca.2016.02.003_bb0130 article-title: Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy publication-title: J. Diabetes Res. doi: 10.1155/2014/790902 – volume: 10 start-page: 185 year: 2010 ident: 10.1016/j.cca.2016.02.003_bb0030 article-title: Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy publication-title: Clin. Exp. Med. doi: 10.1007/s10238-009-0084-7 – volume: 30 start-page: 1272 year: 2013 ident: 10.1016/j.cca.2016.02.003_bb0005 article-title: Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review publication-title: Diabet. Med. doi: 10.1111/dme.12274 – volume: 3 year: 2008 ident: 10.1016/j.cca.2016.02.003_bb0050 article-title: Fetuin-A induces cytokine expression and suppresses adiponectin production publication-title: PLoS One doi: 10.1371/journal.pone.0001765 – volume: 18 start-page: 1279 year: 2012 ident: 10.1016/j.cca.2016.02.003_bb0135 article-title: Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance publication-title: Nat. Med. doi: 10.1038/nm.2851 – volume: 62 start-page: 879 year: 2015 ident: 10.1016/j.cca.2016.02.003_bb0060 article-title: Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes publication-title: Endocr. J. doi: 10.1507/endocrj.EJ15-0152 – volume: 14 start-page: 376 year: 2014 ident: 10.1016/j.cca.2016.02.003_bb0035 article-title: Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema publication-title: Curr. Mol. Med. doi: 10.2174/1566524014666140128114414 |
SSID | ssj0004061 |
Score | 2.282261 |
Snippet | The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR)... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 113 |
SubjectTerms | Aged alpha-2-HS-Glycoprotein - metabolism C-reactive protein C-Reactive Protein - metabolism Diabetes Mellitus, Type 2 - complications Diabetic Nephropathies Diabetic retinopathy Female Fetuin-A Humans Male Middle Aged Type 2 diabetes mellitus Vascular endothelial growth factor Vascular Endothelial Growth Factor A - blood |
Title | Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy |
URI | https://dx.doi.org/10.1016/j.cca.2016.02.003 https://www.ncbi.nlm.nih.gov/pubmed/26851648 https://www.proquest.com/docview/1774157915 |
Volume | 455 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Wwm4ICiv5VEZiRNSqGM7Dx9XK6oF1J6o1FuU-IGCUm_VzR564Wf193UmThZxaA8c83CcZCbjL_Y38wF8ktorJ1KVUN5ionxjk1Jzm8jMGS9FXfKBTXh6lq_O1feL7GIPllMuDNEqx9gfY_oQrcc9x-PbPL5qW8rx5SR-mKZD1ai83IcDIXWezeBg8e3H6uxveiTP00lQjRpMi5sDzQufgAheeazcKe8bnu6Dn8MwdPIMno74kS3iLT6HPRcO4fFykm07hEen42r5C7jFQLC9ZN712zYkC9YRQWjD6mvH2p36bd_dMEMSHR2iTstoXpZN9FSGZ1CGVodOyn7hDzseiwI9rA6WLRNEnEO8ZEO5hzbglUKkew7ujN0wmuNlgsU53tawsZDrJva0203JlGFN-sg3L-H85OvP5SoZdRoSIzPZo5ktLfdJrtKi4EYb16jMOuXyprTaNoqq2Ftfe-8dz0QjvdWll4hEhRFFreQrmIV1cG-ACWW00l7oVCLUMblOLXeyrAtjMbCUxRz4ZJ7KjEXMSUujqya22u8KLVqRRSsuqPLpHD7vmlzFCh4Pnawmm1f_uGGFI8xDzT5O_lGhuWnNpQ5uvd1U-EYQIhU6zebwOjrO7i5EjnA3V-Xb_-v0HTyhrUgjeg-z_nrrPiBC6psj2P_yJz0av4M7_eYRnQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSgXBOW1PI3ECSnUsZ2Hj9WKaoFuT63Um5X4gVIFb9XNHnrpz-rvY8ZOFnFoD1wTJ7Y8k_EX-5v5CPkslJeO5zLDvMVM-tZmtWI2E4UzXvCmZpFNuDwpF2fyx3lxvkPmUy4M0irH2J9ieozW45WDcTYPLrsOc3wZih_meawaVdYPyENZiAp5fV9v_vI8cMWa5NSw-XS0GUleMH6kd5Wpbqe4a3G6C3zGRejoKXkyokd6mAb4jOy4sE_25pNo2z55tBzPyp-TWwgDm9_Uu2HTheyQ9kgPWtPmytFuq3079NfUoEBHD5jTUtyVpRM5lUILzM_qwUXpL_hdh3tJnoc2wdJ5BngzRksaiz10Ad4UEtkzOjN0Q3GHl3Kadng7Q8cyruvU0_YyplKGFaojX78gZ0ffTueLbFRpyIwoxABGtnjYJ5jMq4oZZVwrC-ukK9vaKttKrGFvfeO9d6zgrfBW1V4ADuWGV40UL8luWAX3mlAujZLKc5ULADqmVLllTtRNZSyElbqaETaZR5uxhDkqafR64qpdaLCoRotqxrHu6Yx82T5ymep33NdYTjbX_zihhvXlvsc-Tf6hwdx44tIEt9qsNcwIAKRK5cWMvEqOsx0FLwHslrJ-83-dfiR7i9PlsT7-fvLzLXmMdxKh6B3ZHa427j1gpaH9EL-FP1WoEmg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+fetuin-A+levels+are+independently+correlated+with+vascular+endothelial+growth+factor+and+C-reactive+protein+concentrations+in+type+2+diabetic+patients+with+diabetic+retinopathy&rft.jtitle=Clinica+chimica+acta&rft.au=Zhou%2C+Zhong-Wei&rft.au=Ju%2C+Hui-Xiang&rft.au=Sun%2C+Ming-Zhong&rft.au=Fu%2C+Qing-Ping&rft.date=2016-04-01&rft.issn=1873-3492&rft.eissn=1873-3492&rft.volume=455&rft.spage=113&rft_id=info:doi/10.1016%2Fj.cca.2016.02.003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-8981&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-8981&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-8981&client=summon |